Every material Form 8-K Colgate-Palmolive filed with the SEC in 2023, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Colgate-Palmolive reported third quarter 2023 net sales of $4,915 million, up 10.5% from a year earlier, and GAAP diluted earnings per share of $0.86, up 16% from $0.74. The company raised its full-year 2023 financial guidance for net sales growth and organic sales growth, which signals higher expected results for shareholders.
Third quarter 2023 net sales were $4,915 million, up 10.5% from $4,455 million in the year-earlier quarter.
GAAP diluted EPS was $0.86 versus $0.74, up 16%; Base Business (non-GAAP) EPS also rose 16% to $0.86.
Full-year 2023 net sales growth guidance was raised to 6% to 8% from 5% to 8%.
Full-year 2023 organic sales growth guidance was raised to 7% to 8% from 5% to 7%.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Colgate-Palmolive filing is on SEC EDGAR ↗. 8-K briefs of other companies →